Page last updated: 2024-10-27

gemfibrozil and Hyperinsulinism

gemfibrozil has been researched along with Hyperinsulinism in 1 studies

Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.

Research Excerpts

ExcerptRelevanceReference
"We studied the effects of gemfibrozil on glucose and fatty acid metabolism in subjects with mild endogenous hypertriglyceridemia."9.08Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. ( Knudsen, P; Sane, T; Taskinen, MR; Vuorinen-Markkola, H; Yki-Järvinen, H, 1995)
"We studied the effects of gemfibrozil on glucose and fatty acid metabolism in subjects with mild endogenous hypertriglyceridemia."5.08Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. ( Knudsen, P; Sane, T; Taskinen, MR; Vuorinen-Markkola, H; Yki-Järvinen, H, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sane, T1
Knudsen, P1
Vuorinen-Markkola, H1
Yki-Järvinen, H1
Taskinen, MR1

Trials

1 trial available for gemfibrozil and Hyperinsulinism

ArticleYear
Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.
    Metabolism: clinical and experimental, 1995, Volume: 44, Issue:5

    Topics: Analysis of Variance; Apolipoprotein A-II; Blood Glucose; Cholesterol; Circadian Rhythm; Double-Blin

1995